Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma After Radiation Therapy/Anthracycline Chemotherapy

University of Rochester1 site in 1 country32 target enrollmentAugust 2008

ConditionsHodgkin Disease Lymphoma, Non-Hodgkin

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hodgkin Disease
Sponsor: University of Rochester
Enrollment: 32
Locations: 1
Primary Endpoint: Measure changes in Cardiac ejection fraction score
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study is to inquire by mailed survey regarding the cardiac and general health of patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation therapy/anthracycline chemotherapy.

Registry

clinicaltrials.gov

Start Date

August 2008

End Date

April 9, 2020

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Rochester

Responsible Party

Principal Investigator

Louis Constine

Professor

University of Rochester

Eligibility Criteria

Inclusion Criteria

•All patients with Hodgkin's Lymphoma and Non Hodgkin's lymphoma who underwent Radiation Therapy (RT) to either a mantle or modified mantle field with or without adriamycin at the Wilmot Cancer Center at the University of Rochester are eligible for the study.

Exclusion Criteria

•Any severe preexisting cardiac disease (e.g., arrhythmia, angina, coronary disease, myocardial infarction, or congestive heart failure) prior to diagnosis